Drug Type Small molecule drug |
Synonyms BPR1R024 |
Target |
Action antagonists |
Mechanism CSF-1R antagonists(Colony stimulating factor 1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H21F3N6O2 |
InChIKeyORYMWWSJZRCUSV-UHFFFAOYSA-N |
CAS Registry2503015-75-4 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colonic Cancer | Preclinical | China | 04 Oct 2021 |





